10 employees
Boyue Bio is a service provider specialises in providing core raw materials and overall solutions for in vitro diagnostic reagent customers.
2018
$22M
from 1 investors over 1 rounds
BIOEAST raised $22M on May 9, 2022
Investors: LYFE Capital